Variable | Included studies | Positive cases | Total cases | Rate (%)(95% CI) |
---|---|---|---|---|
Total IPD | 5 | 517 | 590 | Â |
1 | 1 | 2 | 61 | 3.3 (1.2–7.7) |
4 | 1 | 1 | 61 | 1.6 (1.5–4.8) |
5 | 2 | 5 | 67 | 7.0 (0.9–13.0) |
6A | 1 | 1 | 36 | 2.8 (2.6–8.1) |
6B | 3 | 53 | 523 | 7.8 (1.0–14.7) |
9 V | 2 | 4 | 97 | 3.8 (0.0–7.7) |
14 | 4 | 49 | 268 | 15.1 (6.6–23.6) |
19A | 5 | 115 | 590 | 25.8 (15.5–36.0) |
19F | 5 | 242 | 590 | 26.4 (4.0–48.8) |
23F | 5 | 56 | 590 | 8.4 (5.5–11.2) |
PCV7 serotype coverage | 5 | 403 | 590 | 53.0 (32.7–73.3) |
PCV10 serotype coverage | 5 | 412 | 590 | 57.4 (39.7–75.2) |
PCV13 serotype coverage | 5 | 517 | 590 | 83.5 (72.8–94.1) |